Amgen's Q3 revenue up 8% to $10.4B

 Amgen Inc. revealed on Tuesday that its revenue for the third quarter of fiscal 2026 came in at $10.4 billion, up 8% on an annual level.

In the three months ending September 30, year-over-year, net income climbed 20.1% to $3.8 billion and diluted earnings per share (EPS) jumped 19.4% to $7.08. In the nine months of fiscal 2026, compared to the same timeframe in 2025, revenue jumped to $29 billion from $26.9 billion. Net income advanced 26.3% to $8.05 billion and diluted EPS jumped 25% to $14.8 billion. The company lifted its full-year 2026 total revenue guidance to be in the range of $38.9 billion to $39.7 billion and its EPS to be now between $18.34 to $19.28.

"Amgen delivered another strong quarter as our strategy for long-term growth continued to produce results across the enterprise … [This] reinforces our confidence in Amgen's ability to deliver durable growth well into the next decade," CEO Robert Bradway said. Amgen's stock lost 1.71% to $453.38 apiece in after-hours trading.

https://breakingthenews.net/Article/Amgen's-Q3-revenue-up-8-to-dollar10.4B/67473184